209 related articles for article (PubMed ID: 30917954)
1. How I treat chronic myeloid leukemia in children and adolescents.
Hijiya N; Suttorp M
Blood; 2019 May; 133(22):2374-2384. PubMed ID: 30917954
[TBL] [Abstract][Full Text] [Related]
2. Chronic myeloid leukemia (CML) in children: classical and newer therapeutic approaches.
Ampatzidou M; Papadhimitriou SI; Goussetis E; Panagiotou JP; Papadakis V; Polychronopoulou S
Pediatr Hematol Oncol; 2012 Aug; 29(5):389-94. PubMed ID: 22690835
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children.
Phillips LN; Hijiya N
Paediatr Drugs; 2021 May; 23(3):241-251. PubMed ID: 33899163
[TBL] [Abstract][Full Text] [Related]
4. Management of Chronic Myeloid Leukemia in Children and Young Adults.
Ford M; Mauro M; Aftandilian C; Sakamoto KM; Hijiya N
Curr Hematol Malig Rep; 2022 Oct; 17(5):121-126. PubMed ID: 35920965
[TBL] [Abstract][Full Text] [Related]
5. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
Ferri C; Bianchini M; Bengió R; Larripa I
Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Following Bone Marrow Transplantation in Children With Accelerated Phase or Blast Crisis Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors.
Shulman DS; Lee MA; Lehmann LE; Margossian SP
J Pediatr Hematol Oncol; 2016 Nov; 38(8):610-614. PubMed ID: 27403776
[TBL] [Abstract][Full Text] [Related]
7. Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia.
Millot F; Maledon N; Guilhot J; Güneş AM; Kalwak K; Suttorp M
Eur J Cancer; 2019 Jul; 115():17-23. PubMed ID: 31082688
[TBL] [Abstract][Full Text] [Related]
8. Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
Suttorp M; Yaniv I; Schultz KR
Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S115-22. PubMed ID: 21195300
[TBL] [Abstract][Full Text] [Related]
9. Current perspectives for the treatment of chronic myeloid leukemia.
Aladağ E; Haznedaroğlu İC
Turk J Med Sci; 2019 Feb; 49(1):1-10. PubMed ID: 30761815
[TBL] [Abstract][Full Text] [Related]
10. Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring.
Jabbour E; Kantarjian H
Am J Hematol; 2018 Mar; 93(3):442-459. PubMed ID: 29411417
[TBL] [Abstract][Full Text] [Related]
11. The Cure of Chronic Myeloid Leukemia: Are We There Yet?
Saikia T
Curr Oncol Rep; 2018 Feb; 20(2):12. PubMed ID: 29492683
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation.
Suttorp M; Millot F
Hematology Am Soc Hematol Educ Program; 2010; 2010():368-76. PubMed ID: 21239821
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of children with chronic myeloid leukemia: A population-based cohort study.
Egan G; Athale U; Johnston D; Pole JD; Silva M; Zorzi A; Alexander S
Pediatr Blood Cancer; 2020 Sep; 67(9):e28491. PubMed ID: 32589368
[TBL] [Abstract][Full Text] [Related]
14. Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.
Hijiya N; Schultz KR; Metzler M; Millot F; Suttorp M
Blood; 2016 Jan; 127(4):392-9. PubMed ID: 26511135
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.
Kondo T; Nagamura-Inoue T; Tojo A; Nagamura F; Uchida N; Nakamae H; Fukuda T; Mori T; Yano S; Kurokawa M; Ueno H; Kanamori H; Hashimoto H; Onizuka M; Takanashi M; Ichinohe T; Atsuta Y; Ohashi K
Am J Hematol; 2017 Sep; 92(9):902-908. PubMed ID: 28543934
[TBL] [Abstract][Full Text] [Related]
16. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring.
Jabbour E; Kantarjian H
Am J Hematol; 2020 Jun; 95(6):691-709. PubMed ID: 32239758
[TBL] [Abstract][Full Text] [Related]
17. Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry.
Meral Günes A; Millot F; Kalwak K; Lausen B; Sedlacek P; Versluys AB; Dworzak M; De Moerloose B; Suttorp M
Pediatr Blood Cancer; 2021 Jan; 68(1):e28706. PubMed ID: 33034135
[TBL] [Abstract][Full Text] [Related]
18. NKG2A Down-Regulation by Dasatinib Enhances Natural Killer Cytotoxicity and Accelerates Effective Treatment Responses in Patients With Chronic Myeloid Leukemia.
Chang MC; Cheng HI; Hsu K; Hsu YN; Kao CW; Chang YF; Lim KH; Chen CG
Front Immunol; 2018; 9():3152. PubMed ID: 30705677
[TBL] [Abstract][Full Text] [Related]
19. [State-of-the-art management of CML in 2015 and future prospects].
Kimura S
Rinsho Ketsueki; 2015 Oct; 56(10):2005-14. PubMed ID: 26458439
[TBL] [Abstract][Full Text] [Related]
20. Chronic myeloid leukemia-transplantation in the tyrosine kinase era.
Innes AJ; Apperley JF
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1037-53. PubMed ID: 25459178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]